$ENS

Berks battery company buying competitor for $320 million

EnerSys (NYSE: ENS) is acquiring Ultralife (NASDAQ:ULBI) for $320 million, or $16.00 per share, a 166% premium. Ultralife generated $191 million in fiscal 2025 revenue. The deal aims to expand EnerSys's defense power platform, pending regulatory approval.

Original reporting
Published Oct 28, 2026, 1:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ENS
Neutral
high confidence
Mentioned
$ENS · $ULBI
Relevance
9/10
AlphAI data visualization · based on wfmz.com
Decision brief

The 30-second read

$ENSNeutralHigh
01

Why it matters

The acquisition creates a broader product portfolio for EnerSys and removes a competitor, potentially improving market share in defense contracts.

02

Market read

A $320 million M&A deal with a 166% premium, likely to influence defense‑battery sector dynamics and affect both ENS and ULBI stock movements.

03

What to watch

Financing terms and potential regulatory scrutiny could delay closing and affect the deal's net benefit.

Relevance 9/10Novelty 9/10Timing: today, pre‑market and early trading

Background

EnerSys, the world’s largest industrial battery maker, is expanding its defense power platform by acquiring Ultralife, a specialist in military communications batteries.

Company-level read

Ticker impact

$ENSNeutralHigh confidence
Context

EnerSys announced a $320 million acquisition of Ultralife, offering $16 per share, a 166% premium.

Expected impact

likely modest pressure as the market prices in the acquisition cost and integration risk.

Evidence & confidence

The deal size is material but the stock showed little immediate reaction; investors may weigh financing and synergies.

$ULBIBullishHigh confidence
Context

Ultralife is being taken private at $16 per share, a 166% premium to its prior close.

Expected impact

upward pressure as shareholders capture the premium before the tender closes.

Evidence & confidence

A large premium typically drives the share price toward the offer price in the tender period.

Market effects

Consolidation in the industrial battery and defense power market may tighten supply and spur further M&A.

U.S. defense‑related battery manufacturers could see increased investor interest.

The deal underscores growing demand for electrified battlefield solutions worldwide.

Counterpoint

The premium may be excessive; integration risk could erode value for EnerSys shareholders.

Key entities

  • EnerSys

    Acquirer, ticker ENS, industrial battery manufacturer.

  • Ultralife

    Target, ticker ULBI, maker of batteries for military communications.

Related articles

$ULBIMed

Freedom: Ultralife upside after acquisition announcement is almost exhausted

Ultralife (ULBI) shares rose 145.4% to $15.61 after EnerSys (ENS) agreed to acquire it for $16 per share, a 166% premium. The deal, valued at $320M, is expected to close in Q1 2027. Analyst Vladimir Chernov sees limited upside for ULBI, with shares likely staying in the $15.5–16 range until the deal closes. ENS expects cost savings and EPS growth post-acquisition.

$ENSMedAI 8/10

EnerSys to acquire Ultralife for $320 million

EnerSys (ENS) to acquire Ultralife (ULBI) for $320M, or $16 per share. The deal, expected to close in Q1 2027, aims to expand EnerSys's defense power platform. Ultralife generated $191M revenue in fiscal 2025. EnerSys expects $15-20M in annual cost synergies within 18 months.

$ENSHighAI 9/10

EnerSys Pays 166% Premium for Ultralife to Expand Defense Batteries

EnerSys (ENS) will acquire Ultralife (ULBI) for $16.00 per share, a 166% premium, with a $320M enterprise value. The deal expands EnerSys' defense business, adding U.S. manufacturing for compliant batteries. EnerSys expects $15M-$20M in annual cost synergies and EPS growth within 18 months. Ultralife's 2025 revenue was $191M. The deal, funded by cash, requires majority shareholder approval and regulatory clearance, expected to close in Q1 2027.

$ULBIHigh

Ultralife to Be Acquired by EnerSys for $16 Per Share in Cash

Ultralife (ULBI) agreed to be acquired by EnerSys for $16 per share in cash. The deal requires a tender offer and merger, with no financing condition. Stockholders owning 40.3% of shares support the deal but do not meet the minimum tender condition alone. The merger agreement includes repayment of Ultralife's outstanding credit agreement at closing.